PR07, NCIC PR.3: A Randomised Trial of Hormone Therapy Plus Radical Radiotherapy Versus Hormone Therapy Alone in Non-Metastatic Prostate Cancer
What is this study about?
The PR07 trial was conducted as a collaboration between the MRC CTU and the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG). The trial closed to recruitment in 2005 with over 1200 patients; patients remain on follow up. The aim of the trial was to evaluate whether there was a benefit from the addition of external beam radiation therapy to the treatment of patients with non-metastatic prostate cancer who have not had a radical prostatectomy and are receiving hormonal therapy.
Who is included?
Men with non-metastatic prostate cancer
When is it taking place?
Patients were recruited from 1995 in Canada and 1999 in the UK; recruitment closed in 2005
Where is it taking place?
Hospitals throughout the UK and Canada
Who is funding the study?
Medical Research Council
|Type of study:||Randomised trial|
|MAMS||This is a multi arm multi stage study|
|Also included in this study:||Health Economics|
Quality of life outcomes
NHS Information Centre flagging
|Registration numbers:||Registered with the number ISRCTN24991896|
Back to the top of page